Show simple item record

T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas

dc.contributor.authorPoliti, Letterio S.
dc.contributor.authorBrugnara, G.
dc.contributor.authorCastellano, A.
dc.contributor.authorCadioli, M.
dc.contributor.authorAltabella, L.
dc.contributor.authorPeviani, M.
dc.contributor.authorMazzoleni, S.
dc.contributor.authorFalini, A.
dc.contributor.authorGalli, R.
dc.date2022-08-11T08:10:46.000
dc.date.accessioned2022-08-23T17:19:38Z
dc.date.available2022-08-23T17:19:38Z
dc.date.issued2016-06-01
dc.date.submitted2017-05-15
dc.identifier.citationAJNR Am J Neuroradiol. 2016 Jun;37(6):E49-51. Mar 17. <a href="https://doi.org/10.3174/ajnr.A4774">Link to article on publisher's site</a>
dc.identifier.issn0195-6108 (Linking)
dc.identifier.doi10.3174/ajnr.A4774
dc.identifier.pmid26988813
dc.identifier.urihttp://hdl.handle.net/20.500.14038/48122
dc.description.abstractWe read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=26988813&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.3174/ajnr.A4774
dc.subjectNeoplasms
dc.subjectNeurology
dc.subjectRadiology
dc.titleT1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas
dc.typeResponse or Comment
dc.source.journaltitleAJNR. American journal of neuroradiology
dc.source.volume37
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/radiology_pubs/229
dc.identifier.contextkey10166375
html.description.abstract<p>We read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).</p>
dc.identifier.submissionpathradiology_pubs/229
dc.contributor.departmentDepartment of Radiology
dc.source.pagesE49-51


This item appears in the following Collection(s)

Show simple item record